Andrew Chase

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Thomas Ernst, Andrew Chase, Joannah Score et al. · Nature Genetics · 2010 · 1.1K citations

Life Sciences, Genetics, Molecular Biology +14

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Jane F. Apperley, Martine Gardembas, Junia V. Melo et al. · New England Journal of Medicine · 2002 · 631 citations · Full text

Medicine, Hematology, Molecular Genetics +16

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Rocco Piazza, Simona Valletta, Nils Winkelmann et al. · Nature Genetics · 2012 · 425 citations · Full text

Medicine, Genetics, Oncology +11

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Amy V. Jones, Andrew Chase, Richard T. Silver et al. · Nature Genetics · 2009 · 384 citations · Full text

Medicine, Genetics, Hematology +13

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

Andrew Chase, J Bungey, JM Goldman · Blood · 1993 · 378 citations · Full text

Medicine, Hematology, Molecular Biology +13